Abstract
Human medicines European public assessment report (EPAR): Topotecan Actavis, topotecan, Uterine Cervical Neoplasms,Small Cell Lung Carcinoma, Date of authorisation: 24/07/2009, Revision: 6, Status: Withdrawn
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have